Breaking News

Tweet TWEET

Avanir Pharmaceuticals to Host Investor Day on October 29, 2013

       Avanir Pharmaceuticals to Host Investor Day on October 29, 2013

- Webcast to Begin at 12:30 p.m. Eastern time -

PR Newswire

ALISO VIEJO, Calif., Oct. 23, 2013

ALISO VIEJO, Calif., Oct. 23, 2013 /PRNewswire/ --Avanir Pharmaceuticals,
Inc. (NASDAQ: AVNR) will host a live webcast in conjunction with its Investor
Relations Day on Tuesday, October 29, 2013 at 12:30 p.m. ET in New York City.

(Logo: http://photos.prnewswire.com/prnh/20130207/LA55901LOGO)

To view and listen to the webcast please visit our website at
http://ir.avanir.com. Visitors will also be able to view and listen to an
archive copy of the webcast found in the Investor Relations section of
www.avanir.com. The archive will be available for 30 days following the event.

For more information on the Investor Relations Day please refer to contact
information within this press release.

About Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on
bringing innovative medicines to patients with central nervous system
disorders of high unmet medical need. As part of our commitment, we have
extensively invested in our pipeline and are dedicated to advancing medicines
that can substantially improve the lives of patients and their loved ones. For
more information about Avanir, please visit www.avanir.com.

AVANIR® is a trademark or registered trademark of Avanir Pharmaceuticals, Inc.
in the United States and other countries.

^©2013 Avanir Pharmaceuticals, Inc. All Rights Reserved.

Avanir Investor & Media Contact
Ian Clements, PhD
ir@avanir.com
+1 (949) 389-6700

Burns McClellan Contact
Ami Bavishi
abavishi@burnsmc.com
+1 (212) 213-0006



SOURCE Avanir Pharmaceuticals, Inc.

Website: www.avanir.com
 
Press spacebar to pause and continue. Press esc to stop.